pyrazines has been researched along with Protein Folding Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chosa, M; Nagase, K; Tobinai, K; Watanabe, T | 1 |
| Gudkov, AV; Komarov, AP; Neznanov, N; Neznanova, L; Stanhope-Baker, P | 1 |
| Repasky, EA; Subjeck, JR | 1 |
3 other study(ies) available for pyrazines and Protein Folding Diseases
| Article | Year |
|---|---|
Schwann cell autophagy induced by SAHA, 17-AAG, or clonazepam can reduce bortezomib-induced peripheral neuropathy.
Topics: Animals; Antineoplastic Agents; Autophagy; Benzoquinones; Boronic Acids; Bortezomib; Cell Division; Cell Line, Tumor; Clonazepam; HSP90 Heat-Shock Proteins; Lactams, Macrocyclic; Multiple Myeloma; Neurilemmoma; Protein Folding; Proteostasis Deficiencies; Pyrazines; Rats; Schwann Cells | 2010 |
Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cell Line, Tumor; Combined Modality Therapy; Drug Synergism; HCT116 Cells; Heat-Shock Response; HeLa Cells; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Hyperthermia, Induced; Mice; Mice, Inbred BALB C; Multiple Myeloma; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteostasis Deficiencies; Puromycin; Pyrazines | 2011 |
Heat shock proteins and cancer therapy: the trail grows hotter!
Topics: Animals; Antineoplastic Agents; Boronic Acids; Humans; Multiple Myeloma; Proteasome Inhibitors; Proteostasis Deficiencies; Pyrazines | 2011 |